| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/16/1994 | US5338833 Carboxy terminal IL-6 muteins |
| 08/16/1994 | US5338830 Cyclic peptides having diuretic and vasodilation activity |
| 08/16/1994 | US5338683 Genetic engineering, vaccines |
| 08/16/1994 | US5338679 Vertebrate poxvoris expression vector under the control of entomopoxvirus spheroidin gene promoter |
| 08/16/1994 | US5338678 Expression of DNA sequences encoding a thermally stable cytosine deaminase from saccharomyces |
| 08/16/1994 | US5338676 Genetically engineered protein or enzyme |
| 08/16/1994 | US5338671 Reduce formation of non-specific products in polymerase chain reactions |
| 08/16/1994 | US5338669 Transfecting ligated nucleic acid into eukaryotic host cell; culturing |
| 08/16/1994 | US5338665 Peptide library and screening method |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/16/1994 | US5338546 Substituting amino acids; vascular system disorders |
| 08/16/1994 | US5338544 Genetically engineered from Bacillus thuringiensis |
| 08/16/1994 | US5338532 Starburst conjugates |
| 08/13/1994 | CA2115522A1 Hst-2 mutein, dna coding for the same and preparation thereof |
| 08/13/1994 | CA2115507A1 .beta.-tubulin from acremonium chrysogenum, its preparation and use |
| 08/13/1994 | CA2115465A1 Highly alkaline proteases, dna sequences encoding them and process for their production |
| 08/11/1994 | DE4404124A1 Mutierte Tumor-Nekrose-Faktor-Proteine Mutant tumor necrosis factor-proteins |
| 08/11/1994 | DE4303744A1 Canine growth hormone |
| 08/10/1994 | EP0610046A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispesific fusion proteins in a mammalian cell |
| 08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| 08/10/1994 | EP0609722A1 An in vitro method for detecting the presence of invasive stimuli in mammals |
| 08/10/1994 | EP0609580A1 Recombinant CMV neutralising proteins |
| 08/10/1994 | EP0609393A1 VIRULENCE ASSOCIATED PROTEINS IN $i(BORRELIA BURGDORFERI (Bb)) |
| 08/10/1994 | EP0609359A1 Dimorphism genes in fungi |
| 08/10/1994 | EP0609280A1 Human il-3 variants |
| 08/10/1994 | EP0609242A1 New thrombin-inhibiting protein isolated from ticks. |
| 08/10/1994 | EP0609240A1 Receptor of the thyroid/steroid hormone receptor superfamily |
| 08/10/1994 | EP0524997B1 2'-o-alkyl nucleotides and polymers containing them |
| 08/10/1994 | EP0511979B1 Transgenic plants expressing a prokaryotic ammonium dependent asparagine synthetase |
| 08/10/1994 | EP0424484B1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
| 08/10/1994 | EP0181929B1 Trans-acting transcriptional factors |
| 08/10/1994 | CN1090602A Pseudomonos aeruginosa MSHA fimbria strain and its establishment |
| 08/10/1994 | CN1090584A Synthetic polypeptides |
| 08/10/1994 | CN1090510A Interferon tau compositions and methods of use |
| 08/09/1994 | US5336766 Indoleacetic acid synthetase-encoding gene |
| 08/09/1994 | US5336759 Biologically active peptide derived from frog (frog CNP) |
| 08/09/1994 | US5336758 AIDS vaccines |
| 08/09/1994 | US5336618 Monoclonal antibody of the class IgG1, designated 7E3, reacts readily with both normal human and dog blood platelets while fail to react with thrombasthenic human platelets |
| 08/09/1994 | US5336613 Cephalosporin C acylase |
| 08/09/1994 | US5336611 PB92 serine protease muteins and their use in detergents |
| 08/09/1994 | US5336609 Transformed yeasts for producing lysozyme, plasmids used for this transformation, method of producing lysozyme |
| 08/09/1994 | US5336608 Process for producing NADH oxidase |
| 08/09/1994 | US5336607 Regulated gene expression in streptomycetes |
| 08/09/1994 | US5336603 CD4 adheson variants |
| 08/09/1994 | US5336602 Transforming escherichia cell with DNA sequence and an expression vector, cultivation; genetic engineering; arginine |
| 08/09/1994 | US5336492 Bacillus thuringiensis isolates denoted B.T. PS81F, active against lepidopteran pests |
| 08/09/1994 | US5336412 Using pneumatic pressure differential |
| 08/09/1994 | CA1331356C Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 08/09/1994 | CA1331355C Immunopotentation |
| 08/06/1994 | WO1994017820A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
| 08/06/1994 | CA2126455A1 Liver fluke vaccine and polypeptides useful for same |
| 08/06/1994 | CA2088878A1 Cdnas encoding the gastrin and cck-b receptors |
| 08/05/1994 | CA2114686A1 Mammalian influx peptide transporter |
| 08/04/1994 | WO1994017405A1 Assay method to rule out rupture of membranes in women at risk for imminent delivery |
| 08/04/1994 | WO1994017397A1 Dna complexes with dyes designed for energy transfer as fluorescent markers |
| 08/04/1994 | WO1994017210A1 Amplification of nucleic acid sequences |
| 08/04/1994 | WO1994017208A1 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
| 08/04/1994 | WO1994017207A1 High resolution dna sequencing method using low viscosity medium |
| 08/04/1994 | WO1994017205A1 Nucleotidic sequences hybridizing specifically with a campylobacter jejuni genomic nucleic sequence |
| 08/04/1994 | WO1994017196A1 Detection and treatment of mutations in a cd40 ligand gene |
| 08/04/1994 | WO1994017195A1 Pretreatment of microprojectiles prior to using in a particle gun |
| 08/04/1994 | WO1994017194A1 Nematode-resistant transgenic plants |
| 08/04/1994 | WO1994017193A2 Chimeric l- and p-selectin by exchange of domains - uses thereof |
| 08/04/1994 | WO1994017192A2 Lysosomal targeting of immunogens |
| 08/04/1994 | WO1994017190A1 Polypeptides having amidase activity, genetic tools and host microorganisms for obtaining same |
| 08/04/1994 | WO1994017189A2 Protein kinases |
| 08/04/1994 | WO1994017188A2 Acetyl-coa-carboxylase-gene |
| 08/04/1994 | WO1994017187A1 CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, Pfs230 |
| 08/04/1994 | WO1994017186A1 Novel genes, polypeptides, and compositions for cold tolerance and drought resistance in plants |
| 08/04/1994 | WO1994017185A1 G-csf analog compositions and methods |
| 08/04/1994 | WO1994017184A1 Modulation of physiological responses of lymphocytes by cd38 or antibodies thereto |
| 08/04/1994 | WO1994017183A1 Agents for the prevention and treatment of lesch-nyhan syndrome |
| 08/04/1994 | WO1994017182A1 The l-plastin promoter region and its uses |
| 08/04/1994 | WO1994017180A1 Nuclear localized transcription factor kinases |
| 08/04/1994 | WO1994017176A1 Controlled modification of eukaryotic genomes |
| 08/04/1994 | WO1994017125A1 Structured copolymers used as absorbents, gels and carriers of metal ions |
| 08/04/1994 | WO1994017102A1 Human spasmolytic polypeptide in glycosylated form |
| 08/04/1994 | WO1994017101A1 Max-interacting proteins and related molecules and methods |
| 08/04/1994 | WO1994017100A1 Icam-related protein |
| 08/04/1994 | WO1994017093A1 Oligonucleotide alkylphosphonates and alkylphosphonothioates |
| 08/04/1994 | WO1994017091A2 Foldback triplex-forming oligonucleotides |
| 08/04/1994 | WO1994017087A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | WO1994017086A1 Gene regulation by targeting putative intramolecular triple helix |
| 08/04/1994 | WO1994016821A1 Methods of analysis/separation |
| 08/04/1994 | WO1994016738A1 Antisense polynucleotide inhibition of human growth factor-sensitive cancer cells |
| 08/04/1994 | WO1994016737A1 Compositions and methods for delivery of genetic material |
| 08/04/1994 | WO1994016736A1 Localization of therapeutic agents |
| 08/04/1994 | WO1994016730A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | WO1994016722A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | WO1994016718A1 Genetic modification of neural stem cells |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |
| 08/04/1994 | WO1994016713A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | WO1994016681A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | WO1994016570A1 Production of human recombinant collagen in the milk of transgenic animals |
| 08/04/1994 | WO1994016565A1 Aprotinin and synergistic combinations thereof with lectins as larvicides against insect pests of agronomic crops, harvested material thereof, and products obtained from the harvested material |
| 08/04/1994 | WO1994016557A1 Transgenic animal model system for human cutaneous melanoma |
| 08/04/1994 | WO1994016556A1 Transgenic mammals |
| 08/04/1994 | WO1994016550A1 Tomato spotted wilt virus |
| 08/04/1994 | WO1994013825A3 A disease resistance gene from maize as a selectable marker and gene identification probe |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |